| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 423.08B | 380.08B | 355.17B | 331.83B | 261.09B |
| Gross Profit | 117.30B | 107.54B | 94.06B | 123.03B | 62.64B |
| EBITDA | 75.55B | 74.85B | 70.89B | 66.65B | 60.14B |
| Net Income | 50.18B | 45.99B | 45.82B | 44.08B | 39.48B |
Balance Sheet | |||||
| Total Assets | 371.96B | 306.30B | 275.63B | 234.96B | 205.82B |
| Cash, Cash Equivalents and Short-Term Investments | 148.48B | 112.36B | 95.72B | 76.64B | 72.24B |
| Total Debt | 23.10B | 21.87B | 20.71B | 15.41B | 13.91B |
| Total Liabilities | 130.88B | 79.19B | 75.37B | 68.97B | 62.90B |
| Stockholders Equity | 240.25B | 226.98B | 200.17B | 165.92B | 142.87B |
Cash Flow | |||||
| Free Cash Flow | 43.06B | 35.96B | 48.26B | 21.55B | 21.93B |
| Operating Cash Flow | 52.36B | 45.46B | 56.70B | 30.95B | 32.51B |
| Investing Cash Flow | -23.09B | -17.38B | -39.12B | -3.31B | -16.45B |
| Financing Cash Flow | -28.23B | -25.74B | -22.69B | -19.32B | -16.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹8.81T | 15.55 | ― | 3.55% | 4.58% | 1.36% | |
70 Outperform | ₹3.23T | 20.22 | ― | 2.86% | 11.18% | -4.28% | |
69 Neutral | ₹4.73T | 14.83 | ― | 2.70% | 9.61% | 11.08% | |
68 Neutral | ₹2.09T | 14.04 | ― | 4.05% | 3.97% | 0.34% | |
67 Neutral | ₹1.28T | 21.36 | ― | 1.08% | 11.31% | 9.00% | |
65 Neutral | ₹1.44T | 22.66 | ― | 2.76% | 7.22% | 12.99% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |